Innocan Pharma Highlights Breakthrough Narrative Review on Liposomal Synthetic CBD for Chronic Pain: A Novel Non-Opioid Analgesic Approach ...Middle East

HERZLIYA, Israel and CALGARY, AB, June 13, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries proudly announces the third party publication of a peer-reviewed...

Read More Details
Finally We wish PressBee provided you with enough information of ( Innocan Pharma Highlights Breakthrough Narrative Review on Liposomal Synthetic CBD for Chronic Pain: A Novel Non-Opioid Analgesic Approach )

Also on site :

• Petroleum Ministry activates emergency plan for natural gas supply
• Amazon Is Selling a 'Buttery Soft' $60 2-Piece Set for Just $30, and Shoppers Say It 'Feels Like Spanx Air Essentials'
• Ben Gurion Airport closed until further notice